Horizon2020 MMPredict video on personalised medicine tools for myeloma patients now available in five languages

 

Horizon2020 MMPredict video on personalised medicine tools for myeloma patients now available in five languages

 

Myeloma Patients Europe (MPE) is participating in the Horizon 2020 project, MMPredict, aimed to develop a personalised medicine tool to predict the most effective treatment strategy for individual myeloma patients. To explain the main goals ofMMPredict, MPE filmed a video with some partners working in the project consortium. Now this video,recorded in English, has been translatedinto four additional languages: German, Spanish, Dutch and Italian.
To activate the subtitles in your preferred language, please go to “settings”, as highlighted in the image below, and select the relevant language:

For further information, please visit the Horizon2020 website. You can also find further information on the MPE website here or the MPE Q&A on this project.

 

MPE members survey on AL amyloidosis

 

AL amyloidosis is a myeloma-related condition affecting 9 people per 1 million in Europe. Since 2016, Myeloma Patients Europe (MPE) has been working with the AL amyloidosis patient advocacy community to support its growth. This is because AL amyloidosis is very similar to myeloma and it is estimated that around 20% of myeloma patients also develop AL amyloidosis at some point.

MPE is running a short survey with members to understand the role, if any, myeloma patient organisations play in supporting the AL amyloidosis community in Europe. We also want to know if you are aware of any organisations in your country that provide support for AL amyloidosis patients, their caregivers and family members.

We anticipate it will take no longer than 5 minutes to complete.

 

Registration for the MPE Annual General Meeting 2019 is open

 

Once a year MPE holds its Annual General Meeting (AGM). All MPE full members and sponsors are invited to this event which includes a one-and-a-half day Masterclass to provide training to MPE members with scientific sessions, given by the most important specialists in Europe, and advocacy sessions.

The MPE AGM 2019 will be held in Munich (Germany) from 15 to 17 March 2019. Please, find here some information about venue, logistics and the preliminary agenda.

Registration is now open. If you are planning to attend, please read carefully expenses and reimbursement rules and get registered here.

Looking forward to meeting you in Munich!

 
 
 
Copyright © 2018 Myeloma Patients Europe, All rights reserved. 
MPE full members 

Our mailing address is: 

Myeloma Patients Europe

Avenue Louise 149/24 1050 Brussels Belgium

Brussels 1050

Belgium

Add us to your address book

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list